Treatment-resistant schizophrenia--the role of clozapine.
about
Refractory schizophrenia and atypical antipsychoticsElectroconvulsive therapy for treatment-resistant schizophreniaCurrent perspectives in the treatment of resistant schizophreniaOestrogen (adjunct) versus placebo for women with schizophreniaPrevalence and Predictors of Clozapine-Associated Constipation: A Systematic Review and Meta-AnalysisChemotherapy for Hodgkin's lymphoma in a patient receiving clozapine for treatment-resistant schizophrenia: use of the Mental Capacity Act 2005A Role for Estrogen in Schizophrenia: Clinical and Preclinical FindingsTreatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychoticsDrug models of schizophreniaClozapine: an effective treatment for seriously violent and psychopathic men with antisocial personality disorder in a UK high-security hospitalWhat do patients in a lithium outpatient clinic know about lithium therapy?Glutamatergic synaptic dysregulation in schizophrenia: therapeutic implications.Successful clozapine re-challenge in a patient with three previous episodes of clozapine-associated blood dyscrasia.Study protocol for the development of a European measure of best practice for people with long term mental health problems in institutional care (DEMoBinc).A systematic review of the international published literature relating to quality of institutional care for people with longer term mental health problemsChemistry-based molecular signature underlying the atypia of clozapine.The development of the Quality Indicator for Rehabilitative Care (QuIRC): a measure of best practice for facilities for people with longer term mental health problems.Predictors of type 2 diabetes in a nationally representative sample of adults with psychosis.Synaptic proteins in the postmortem anterior cingulate cortex in schizophrenia: relationship to treatment and treatment response.Quality of longer term mental health facilities in Europe: validation of the quality indicator for rehabilitative care against service users' views.The Porirua Protocol in the Treatment of Clozapine-Induced Gastrointestinal Hypomotility and Constipation: A Pre- and Post-Treatment Study.Managing suicide risk in patients with schizophreniaSelective serotonin 3 receptor antagonist treatment for schizophrenia: meta-analysis and systematic review.Study protocol: cluster randomised controlled trial to assess the clinical and cost effectiveness of a staff training intervention in inpatient mental health rehabilitation units in increasing service users' engagement in activitiesClinical predictors of therapeutic response to antipsychotics in schizophreniaTreatment resistant schizophrenia: a comprehensive survey of randomised controlled trials.Pharmacologic treatment of first-episode schizophrenia: a review of the literatureClinical outcomes and costs for people with complex psychosis; a naturalistic prospective cohort study of mental health rehabilitation service users in EnglandCognition, schizophrenia, and the atypical antipsychotic drugsExome sequencing followed by large-scale genotyping suggests a limited role for moderately rare risk factors of strong effect in schizophreniaSwitching antipsychotics: an updated review with a focus on quetiapine.Pharmacogenetics of antipsychotics: recent progress and methodological issues.Establishing the characteristics of an effective pharmacogenetic test for clozapine-induced agranulocytosis.Genetic variation in BDNF is associated with antipsychotic treatment resistance in patients with schizophrenia.Association between antipsychotic/antidepressant drug treatments and hospital admissions in schizophrenia assessed using a mental health case registerAdding or switching antipsychotic medications in treatment-refractory schizophrenia.Classics in chemical neuroscience: clozapine.Gene-expression analysis of clozapine treatment in whole blood of patients with psychosisFactors associated with response to clozapine in schizophrenia: a review.Dopaminergic synapses in the caudate of subjects with schizophrenia: relationship to treatment response
P2860
Q22241831-21B6060C-0665-425E-9878-ED25C4F1B885Q24187594-CF85AC9B-CBB8-4FEC-B086-F5A8F3EEDED2Q24650594-6E037D9C-5D3A-4ED9-BF98-C72C4461CEE8Q26471707-C8972432-B09F-4CFB-AD6E-39C465EC2C4DQ26748476-A8AD938A-DB22-40A7-B094-7EAB38641950Q26772273-C4BAAF8A-F591-482D-BE14-CA8315C553C4Q26778420-F0A6D95E-D711-4B11-8CE2-5C9BD9B19405Q28079065-70B92EFE-73E4-44F3-B3A1-AC8335497606Q28084198-89B4C9A6-6926-40D8-9DB7-966D964AE029Q28237349-0D654F9D-8B31-48D0-92D1-7633744CFE57Q28361173-F6137C1E-299F-4941-8FEE-FEEF04DB26E1Q30387014-F14719B3-51A6-45BD-95E3-BC8B4678457FQ30490990-1EFC8311-4BF7-455E-83F5-1B683F4351AEQ33467121-A1243B89-1D91-4803-91B5-508E73A157DFQ33500672-08A4AFB9-BB63-4AF5-8854-E9C2808FB0CAQ33707728-F07CCECF-26BD-4690-B7E8-9BF3C31CDA43Q33833114-8F30D79D-9722-4F59-B271-3FD6420DE7FCQ33915509-AA4E3802-F651-4970-8C04-A30859423121Q33923576-5B294EC9-6C71-4400-9E09-FDAB6B932763Q34295687-0AEE83D6-4DBA-4CD0-833A-9C8552EC6551Q34544343-316C8A93-E34D-4700-8CC0-D345AFB40D64Q34664040-ADAE4140-A3EF-4D08-ACAA-E6B64F250B8AQ34879435-C8B4FD3F-2BD2-40B8-AD9C-57F4FD225099Q34975109-504D4F38-4871-4BBA-9523-94C10A008018Q35109168-57C76017-5A7D-4527-AF08-8025487C3E9EQ35256929-5D208C31-AC8F-487C-A884-9F7F48657566Q35977796-BA1D9023-3385-4F3D-A467-CCF02ABB7AC0Q35983059-32FEF2AF-12D7-44B6-9C68-D3F2EA9DC103Q36086075-F4AC9EF8-1058-4501-A8C4-20F8EBF5ECF0Q36152879-91D53C3B-D673-4061-89CA-329152A990B0Q36276541-2E0F84B0-D0FB-4524-B29E-498C482F64A2Q36539833-89BBE3CC-CEBB-4017-8A27-3F712F1BE5D5Q36605131-15BF1058-FFBD-445C-BB71-B16B6467232EQ36756159-24970A22-DEA4-45EC-9D94-D3222446C02EQ36848311-6BC3BC3F-F93D-4474-8D2D-9B7B017F7026Q36905070-316B6C17-49FA-405C-AA0B-2F525D8D56ADQ37025878-2C76818E-4EAC-45CE-B15D-FFE7D62050EDQ37229987-3C3852D4-BE0A-4DF1-89B8-6B1E4A351EB3Q37300007-2FBA03B8-8583-44E6-A63D-8A83A618C5F5Q37405204-BCDDF48F-F9F0-4231-A950-CE159BD737C8
P2860
Treatment-resistant schizophrenia--the role of clozapine.
description
1997 nî lūn-bûn
@nan
1997 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Treatment-resistant schizophrenia--the role of clozapine.
@ast
Treatment-resistant schizophrenia--the role of clozapine.
@en
type
label
Treatment-resistant schizophrenia--the role of clozapine.
@ast
Treatment-resistant schizophrenia--the role of clozapine.
@en
prefLabel
Treatment-resistant schizophrenia--the role of clozapine.
@ast
Treatment-resistant schizophrenia--the role of clozapine.
@en
P1476
Treatment-resistant schizophrenia--the role of clozapine.
@en
P2093
Meltzer HY
P356
10.1185/03007999709113338
P407
P577
1997-01-01T00:00:00Z